- Effect of screening and early detection of cognitive impairment (MCI and mild to moderate dementia) on important patient, caregiver, and societal outcomes, including decision-making, advance planning, and caregiver outcomes.
- Effects of caregiver or patient-caregiver dyad interventions on delay or prevention of institutionalization, and the effects of delay in institutionalization on caregivers.
- More consistent definitions and reporting of outcomes to allow comparisons across trials, especially from trials with longer-term follow-up.
- Treatments that affect the long-term clinical course of cognitive impairment.
- Harms and reasons for attrition of trial participants in screening and intervention studies
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults.
Cognitive Impairment in Older Adults: Screening Read full statement 1